Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

Conditions: Arthrofibrosis of Knee Interventions: Drug: Losartan Sponsors: NYU Langone Health Not yet recruiting

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials